Drug resistance revealed by in silico deep mutational scanning and mutation tracker

no code implementations • 5 Mar 2024 • Dong Chen, Gengzhuo Liu, Hongyan Du, JunJie Wee, Rui Wang, Jiahui Chen, Jana Shen, Guo-Wei Wei

As COVID-19 enters its fifth year, it continues to pose a significant global health threat, with the constantly mutating SARS-CoV-2 virus challenging drug effectiveness.

Drug Discovery

Emerging dominant SARS-CoV-2 variants

no code implementations • 18 Oct 2022 • Jiahui Chen, Rui Wang, Yuta Hozumi, Gengzhuo Liu, Yuchi Qiu, Xiaoqi Wei, Guo-Wei Wei

Accurate and reliable forecasting of emerging dominant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants enables policymakers and vaccine makers to get prepared for future waves of infections.